| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/20/2013 | CN102977192A Purification method of carbetocin |
| 03/20/2013 | CN102977191A Potent C3 complement statin analogs |
| 03/20/2013 | CN102977190A Application of monodisperse polymethyl acrylate strong cation exchange chromatography medium in purification of thymopentin |
| 03/20/2013 | CN102977189A Polypeptide combined with FAP (Fibroblast Activation Protein) |
| 03/20/2013 | CN102977188A GNRH (gonadotropin-releasing hormone) peptide variants |
| 03/20/2013 | CN102977187A Bacteriocin inducer peptides |
| 03/20/2013 | CN102276694B Blood pressure lowering functional polypeptide from pig blood and application thereof |
| 03/20/2013 | CN102276693B Blood pressure lowering functional polypeptide from pig blood and application thereof |
| 03/20/2013 | CN102276692B Functional polypeptide and application thereof |
| 03/20/2013 | CN102219831B Antibiotic peptide as well as preparation method and application thereof |
| 03/20/2013 | CN101863963B Helicobacter pylori antigen epitope polypeptide and application thereof |
| 03/20/2013 | CN101838307B K2 polypeptide synthesis product and application thereof |
| 03/20/2013 | CN101838306B K4 polypeptide synthesis product and application thereof |
| 03/20/2013 | CA2783359A1 Opioid peptide esters and methods of use |
| 03/19/2013 | US8399613 Tumour-associated peptides that bind to MHC molecules |
| 03/19/2013 | US8399612 Asymmetric synthesis of peptides |
| 03/19/2013 | US8399211 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 03/19/2013 | CA2500248C Peptide derivative fusion inhibitors of hiv infection |
| 03/19/2013 | CA2440303C Wt1 modified peptide |
| 03/19/2013 | CA2367901C Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 03/19/2013 | CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 03/19/2013 | CA1341634C Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humanin (virus hiv) leurs applications au diagnostic des infections dues acertains de ces virus et, le cas echeant, a la vaccination contre le sida |
| 03/14/2013 | WO2013036889A1 Retrograde transport peptide and use of same for delivery to central nervous system |
| 03/14/2013 | WO2013036208A1 P53 activating peptides |
| 03/14/2013 | WO2013035931A1 Peptide inhibiting matrix metalloproteanases activity and use thereof |
| 03/14/2013 | WO2013035107A1 Therapeutic peptides |
| 03/14/2013 | WO2013034670A1 Preparation of micafungin intermediates |
| 03/14/2013 | WO2013013075A3 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
| 03/14/2013 | WO2013011056A3 Pathology biomarker assay |
| 03/14/2013 | WO2012170842A3 Peptide for protection of allergic respiratory disorders |
| 03/14/2013 | US20130065841 Process for a folate-targeted agent |
| 03/14/2013 | US20130065840 Method and peptide for regulating cellular activity |
| 03/14/2013 | US20130065837 Integrin interaction inhibitors for the treatment of cancer |
| 03/14/2013 | US20130065833 Alkylated sp-b peptoid compounds and related lung surfactant compositions |
| 03/14/2013 | US20130065829 Peptides and supported peptides for treating skin diseases |
| 03/14/2013 | US20130065325 Zwitterionic reagents |
| 03/14/2013 | US20130065308 Cationic lipids |
| 03/14/2013 | US20130064895 Amphiphilic Peptides and Peptide Particles |
| 03/14/2013 | US20130064843 Identification of conserved peptide blocks in homologous polypeptides |
| 03/14/2013 | US20130064842 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
| 03/14/2013 | US20130064841 Immunogenic compositions against human progastrin peptides |
| 03/14/2013 | US20130064840 Hjurp peptides and vaccines including the same |
| 03/14/2013 | US20130064790 Peptides with the capacity to bind to interleukin-10 (il-10) |
| 03/14/2013 | US20130064766 TRICARBONYL TECHNETIUM-99m OR RHENIUM-188 LABELED CYCLIC RGD DERIVATIVES, A PREPARATION METHOD THEREOF, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENESIS-RELATED DISEASES |
| 03/14/2013 | CA2847862A1 Compstatin analogs with improved pharmacokinetic properties |
| 03/13/2013 | EP2566883A1 Novel process for the preparation of leuprolide and its pharmaceutically acceptable salts thereof |
| 03/13/2013 | EP2566882A1 Agents for treating alzheimer's disease |
| 03/13/2013 | EP2566881A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications |
| 03/13/2013 | CN102971336A Peptide for use as a medicament, in particular for the treatment of cancer |
| 03/13/2013 | CN102965304A Daptomycin high-producing strain and preparation method thereof |
| 03/13/2013 | CN102964429A Productive technology for preparing pitocin solution by adopting biological extraction method |
| 03/13/2013 | CN102964428A Kit for detecting soluble leukocyte differentiation antigen 40 ligand and polypeptide ligand |
| 03/13/2013 | CN102964427A Bioactive polypeptide QEPVL, and preparation and application thereof |
| 03/13/2013 | CN102964426A Tumor antigens for prevention and/or treatment of cancer |
| 03/13/2013 | CN102399751B Anti-mycobacterium tuberculosis monoclonal antibody, epitope recognized by anti-mycobacterium tuberculosis monoclonal antibody, and use thereof |
| 03/13/2013 | CN102276697B Helicobacter pylori antigen HLA restricted immuno-dominant epitope peptide and application thereof |
| 03/13/2013 | CN102276691B Antibacterial peptides and preparation method thereof |
| 03/13/2013 | CN102188691B Application of tachyplesin in preparing antihrombotic medicines and health-care products and preparation method thereof |
| 03/13/2013 | CN101980721B Antigendrug excipient comprising synthetic peptide, and mucosal vaccine using the same |
| 03/13/2013 | CN101633636B Peptidomimetic protease inhibitors |
| 03/13/2013 | CN101395173B Template-fixed peptidomimetics with antimicrobial activity |
| 03/13/2013 | CN101384716B HLA-a*3303-restricted WT1 peptide and pharmaceutical composition comprising the same |
| 03/13/2013 | CN101280005B Preparation of PT141 |
| 03/12/2013 | US8394769 Anti-hypertensive agent |
| 03/12/2013 | US8394758 Tumor-targeting peptides and uses thereof |
| 03/12/2013 | US8394601 Peptide biomarkers predictive of renal function decline and kidney disease |
| 03/12/2013 | CA2550085C Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 03/12/2013 | CA2480199C Fp-ghrelin |
| 03/12/2013 | CA2354599C Binding molecules for human factor viii and factor viii-like proteins |
| 03/07/2013 | WO2013033260A1 Use of hdl-related molecules to treat and prevent proinflammatory conditions |
| 03/07/2013 | WO2013032411A1 Silk-based bioactive oligopeptide compositions and manufacturing process therefor |
| 03/07/2013 | WO2013032210A2 Biomembrane permeable composition |
| 03/07/2013 | WO2013031827A1 Rsv mucosal vaccine |
| 03/07/2013 | WO2013030569A2 Peptides |
| 03/07/2013 | WO2013030541A1 Histone deacetylase |
| 03/07/2013 | WO2013030208A1 Cyclosporin derivatives |
| 03/07/2013 | WO2013029182A1 Stable peptide-based furin inhibitors |
| 03/07/2013 | WO2013029180A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | WO2013009690A3 Leukemia stem cell targeting ligands and methods of use |
| 03/07/2013 | US20130060005 Compositions and methods for inhibiting the interaction between cftr and cal |
| 03/07/2013 | US20130060004 Novel Process For The Preparation Of Leuprolide And Its Pharmaceutically Acceptable Salts Thereof |
| 03/07/2013 | US20130059798 Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway |
| 03/07/2013 | US20130059794 Alpha-fetoprotein "ring and tail" peptides |
| 03/07/2013 | US20130059793 Egf receptor mimicking peptides |
| 03/07/2013 | US20130059776 Antiviral Cell-Penetrating Peptides |
| 03/07/2013 | US20130059773 Compounds for the treatment of inflammation and neutropenia |
| 03/07/2013 | US20130058993 Methods and compositions for enhancing wound healing using car peptides |
| 03/07/2013 | US20130058991 Matricryptic ecm peptides for tissue reconstruction |
| 03/07/2013 | US20130058865 99mTc-LABELED 19 AMINO ACID CONTAINING PEPTIDE FOR USE AS PHOSPHATIDYLETHANOLAMINE BINDING MOLECULAR PROBE AND RADIOPHARMACEUTICAL |
| 03/07/2013 | DE112011100556T5 Gering hämolytisches antimimikrobielles Peptid, dessen pharmazeutische Zusammensetzung und Verwendung Low hemolytic antimimikrobielles peptide whose pharmaceutical composition and use |
| 03/07/2013 | CA2846865A1 Use of hdl-related molecules to treat and prevent proinflammatory conditions |
| 03/07/2013 | CA2846287A1 Stable peptide-based pace4 inhibitors |
| 03/07/2013 | CA2846218A1 Peptides |
| 03/07/2013 | CA2845663A1 Cyclosporin derivatives |
| 03/06/2013 | EP2565202A1 Peptide for improving in vivo stability of physiologically active substance or the like and physiologically active substance with improved in vivo stability |
| 03/06/2013 | EP2564863A2 Triazole linked macrocyclic peptides |
| 03/06/2013 | EP2563378A1 Pea protein peptides with anti helicobacter pylori activity |
| 03/06/2013 | CN102958503A SIRTUIN-6-activating peptides, and cosmetic or pharmaceutical compositions including same |
| 03/06/2013 | CN102952180A Preparation method for high-purity echinocandin B |
| 03/06/2013 | CN102952179A Preparation method for high-purity micafungin precursor compound |